Drugs / [U-13C3] glycerol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02833415 | Mar 2016 → Jan 2018 | obesity disorder | University of Texas Southwestern Medical Center | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [U-13C3] glycerol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02833415 ↗ |
| Route | Oral | “following ingestion of [U-13 C3 ]glycerol” PMID 32568464 ↗ Jul 2020 |